User Profile
Corporate
Careers
FAQ
Blog
Pricing
Social
General Modals
Advanced Modals
Search
Wizards
EMBO Global Investigator Network
The EMBO Global Investigator Network supports innovative and creative group leaders producing impactful research in the Life Sciences and who, at the time of application, are within their first six years of setting up their research groups in Chile, India, Singapore, or Taiwan. Global Investigators receive financial support for four years for training and networking activities, providing them with opportunities to form collaborations with scientists in their region and in Europe. They become part of an international network of more than 700 current and former EMBO Young Investigators, Global Investigators, and Installation Grantees. After these four years, they remain associated with the network and have access to some of its benefits. Programme members are selected based on their intellectual independence, originality of their research topic and/or methodological approaches, and whose work will lead to major contributions in their field.
Specialties
Eligibility Requirements
Applications are accepted from candidates who meet the following criteria:
• Applicants should have been an independent group leader for at least one year and for less
than six years on 1 January in the year of application. This means that the applicant should
have obtained the independent status between 1 January 2019 and 1 January 2024 for the
2025 round.
• Applicants must perform research in the life sciences (see EMBO subject areas on page 2)
in Chile, India, Singapore, or Taiwan. International experience and networks are
considered a plus.
• There is no age limit for applicants to the EMBO Global Investigator Network.
• Applicants should have an excellent track record.
• Applicants are expected to have obtained sufficient funding to run their research group.
• Applicants must have published at least one senior author research paper in an
international peer reviewed journal from independent work carried out in their own
research group. Review articles will not be considered.
• Applicants can only be interviewed twice by the selection committee.
Eligible Countries:
Sponsor Details
Sponsor Institute/Organizations: European Molecular Biology Organization (EMBO)
Sponsor Type:
Address: Heidelberg, Germany, at Meyerhofstrasse 1, 69117
Legal & Affiliation Disclaimer
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Grant
Letter Of Intent Deadline:
May 01, 2025
Final Deadline:
May 01, 2025
Funding Amount:
Varies
Host Details
Affiliation: European Molecular Biology Organization (EMBO)
Address: Heidelberg, Germany, at Meyerhofstrasse 1, 69117
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Invite Gmail Contacts